Loading organizations...
Founded in 2015 by Buddy Lyons, Memphis-based Entac Medical develops non-invasive wearable devices that use artificial intelligence and predictive analytics to analyze biological acoustic signals for surgical patient monitoring. The healthcare technology company's flagship diagnostic product, PrevisEA, is designed to predict gastrointestinal impairment and identify patients at risk for severe post-operative complications. To validate this core acoustic technology invented by Chief Technical and Medical Officer John Cromwell, the enterprise conducted clinical trials involving approximately 300 patients across eight academic medical centers. Entac Medical has secured approximately $4.25 million in total venture funding, which includes a $4 million Series B-II equity round raised to support the commercialization of its predictive systems. Advancing toward expected commercialization, the firm filed a 510(k) submission for PrevisEA in March 2021 following one of the largest clinical trials in the gastrointestinal patient population.
Entac Medical has raised $3.8M across 3 funding rounds.
Entac Medical has raised $3.8M in total across 3 funding rounds.
Entac Medical has raised $3.8M across 3 funding rounds. Most recently, it raised $3.0M Series B in February 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2020 | $3M Series B | — | Innova Memphis | Announced |
| May 1, 2018 | $520K Series A | — | Innova Memphis | Announced |
| Jul 1, 2015 | $250K Seed | — | Innova Memphis | Announced |
Entac Medical is a digital health company developing wearable devices that use predictive analytics and AI to analyze biological acoustic signals, forecasting patient adverse events like postoperative ileus (POI) and gastrointestinal impairment (GII).[1][2][4] Their key products, such as PrevisEA and Previs CDP, attach non-invasively to patients post-surgery to detect biomarkers, improving outcomes, reducing hospital readmissions exceeding 20%, and lowering care costs for healthcare providers.[1][4] Founded in 2015 and based in Memphis, Tennessee, the company has raised about $4.25M in Series B funding, remains operational with under 25 employees, and holds patents in acoustic signal analysis for conditions like acute pain and digestive disorders.[4][5]
Entac Medical was co-founded in 2015 by Buddy Lyons (CEO) and Dr. John Cromwell (CMO/CTO), emerging from University of Tennessee technology aimed at addressing GII, which affects about 25% of major abdominal surgery patients and drives high readmission rates.[4][8] The idea stemmed from acoustic biomarkers validated in studies, like a 2019 podium presentation at the American College of Surgeons showing PrevisEA's prospective prediction of POI.[1] Early challenges included financial hurdles—running out of money twice—but persistence led to pivotal moments like $4M funding in Series B (last raised ~2020) and strategic pivots toward commercialization via risk-free hospital trials.[4][5][8]
Entac Medical rides the predictive digital health wave, leveraging AI/IoT wearables amid rising post-surgical complications (20%+ readmissions) and healthcare cost pressures.[1][2][4] Timing aligns with maturing acoustic biomarker research from academic origins (UT) and FDA-adjacent validations, amplified by post-2020 funding for AI-driven medtech.[4][8] Market forces like value-based care and hospital efficiency demands favor non-invasive tools reducing GII risks; Entac influences the ecosystem by pioneering audio analytics, potentially expanding to respiratory events and inspiring Iowa/Memphis medtech hubs through venture partnerships.[5][8]
Entac Medical's path forward hinges on scaling PrevisEA adoption via trials and data, targeting FDA clearance expansions and new indications like bronchospasms amid AI-health convergence.[4][8] Trends in proactive monitoring and acoustic IoT will accelerate growth, evolving their influence from POI prediction to comprehensive AE mitigation in surgery and beyond—positioning them as a nimble player in cost-saving digital health.[2][8] With validated tech and resilient founders, expect partnerships driving commercial momentum, tying back to their core mission of turning acoustic signals into lifesaving foresight.[1]
Entac Medical has raised $3.8M in total across 3 funding rounds.
Entac Medical's investors include Innova Memphis.
